Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations.
Smith KER, Acosta-Medina AA, Dasari S, Ranatunga W, Rech KL, Ravindran A, Young JR, McGarrah PW, Ruan GJ, Zanwar SS, Li JJ, Sartori-Valinotti JC, Snider JN, Witzig TE, Goyal G, Go RS, Abeykoon JP.
Smith KER, et al.
JCO Precis Oncol. 2024 Nov;8:e2400471. doi: 10.1200/PO-24-00471. Epub 2024 Nov 22.
JCO Precis Oncol. 2024.
PMID: 39576953